The program describes a novel approach to engaging patients with psychosis and their families. We seek the development of true collaboration. Critical in this approach is establishing a community of individuals with a common interest that provides support for each other. The support allows the treatment team to secure the patient's trust, develop a therapeutic relationship and do the hard work of creating an optimal clozapine regimen. This session will go on to:

• describe how we develop clozapine regimens that minimize predictable side effects and optimize benefits; 
• share our results in improving patient outcomes.

Presenters: Robert Laitmain, MD & Matcheri Keshavan, MD